133 related articles for article (PubMed ID: 12221685)
1. Enhanced response to basiliximab in a patient with aplastic anemia after treatment with standard immunosuppression.
Berman JA; Patel K; Caro J
Am J Hematol; 2002 Sep; 71(1):64. PubMed ID: 12221685
[No Abstract] [Full Text] [Related]
2. [Combined antithymocyte globulin. cyclosporin. methylprednisolone and granulocyte colony-stimulating factor are effective in a patient with hepatitis-associated severe aplastic anemia].
Kanakura M; Mihara H; Wakabayashi M; Tajima E; Hiramatsu A; Sato A; Imamura A; Miwa H; Kato Y; Nitta M
Nihon Naika Gakkai Zasshi; 2002 Mar; 91(3):1036-8. PubMed ID: 11985078
[No Abstract] [Full Text] [Related]
3. Lower risk of infectious deaths in cardiac transplant patients receiving basiliximab versus anti-thymocyte globulin as induction therapy.
Mattei MF; Redonnet M; Gandjbakhch I; Bandini AM; Billes A; Epailly E; Guillemain R; Lelong B; Pol A; Treilhaud M; Vermes E; Dorent R; Lemay D; Blanc AS; Boissonnat P
J Heart Lung Transplant; 2007 Jul; 26(7):693-9. PubMed ID: 17613399
[TBL] [Abstract][Full Text] [Related]
4. Hepatitis-associated aplastic anemia.
Brown KE; Tisdale J; Barrett AJ; Dunbar CE; Young NS
N Engl J Med; 1997 Apr; 336(15):1059-64. PubMed ID: 9091802
[TBL] [Abstract][Full Text] [Related]
5. Cyclosporin combined with levamisole for refractory or relapsed severe aplastic anaemia.
Shao Y; Li X; Shi J; Ge M; Huang J; Huang Z; Zhang J; Nie N; Zheng Y
Br J Haematol; 2013 Aug; 162(4):552-5. PubMed ID: 23700976
[No Abstract] [Full Text] [Related]
6. Immunosuppressive Therapy for Aplastic Anaemia.
Damodar S
J Assoc Physicians India; 2015 Mar; 63(3 Suppl):16-20. PubMed ID: 26529862
[TBL] [Abstract][Full Text] [Related]
7. Sirolimus and low-dose tacrolimus with antibody induction in kidney transplantation: preliminary results of a pilot study.
Lawen J; Keough-Ryan T; Clase C; Kiberd B
Transplant Proc; 2001; 33(7-8):3223-5. PubMed ID: 11750382
[No Abstract] [Full Text] [Related]
8. [Aplastic anemia and viral hepatitis (posthepatitic aplastic anemia)].
Mikhaĭlova EA; Iadrikhinskaia VN; Savchenko VG
Ter Arkh; 1999; 71(7):64-9. PubMed ID: 10481870
[TBL] [Abstract][Full Text] [Related]
9. Comparison of single bolus ATG and Basiliximab as induction therapy in presensitized renal allograft recipients receiving tacrolimus-based immunosuppressive regimen.
Yang SL; Wang D; Wu WZ; Lin WH; Xu TZ; Cai JQ; Tan JM
Transpl Immunol; 2008 Jan; 18(3):281-5. PubMed ID: 18047938
[TBL] [Abstract][Full Text] [Related]
10. [The use of allogeneic bone marrow transplantation and immunosuppressive therapy in the treatment of patients with acquired aplastic anemia].
Ganapiev AA; Golubovskaia IK; Zalialov IuR; Estrina MA; Afanas'ev BV
Ter Arkh; 2010; 82(7):48-52. PubMed ID: 20853609
[TBL] [Abstract][Full Text] [Related]
11. [Acquired aplastic anemia of the adult. Treatment of 2 cases].
Cabrera ME; Pinto D
Rev Med Chil; 2003 Dec; 131(12):1439-43. PubMed ID: 15022408
[TBL] [Abstract][Full Text] [Related]
12. Basiliximab and mycophenolate mofetil in combination with low-dose cyclosporine and methylprednisolone effectively prevent acute rejection in kidney transplant recipients.
Kovac D; Kotnik V; Kandus A
Transplant Proc; 2005 Dec; 37(10):4230-4. PubMed ID: 16387086
[TBL] [Abstract][Full Text] [Related]
13. Epstein-Barr virus associated pneumonia in an adult patient with severe aplastic anaemia: resolution after the transient withdrawal of cyclosporine.
Potenza L; Barozzi P; Codeluppi M; Morselli M; Forghieri F; Volzone F; Riva G; Pietrosemoli P; Pecorari M; Leonardi G; Torelli G; Luppi M
Am J Hematol; 2007 Oct; 82(10):944-6. PubMed ID: 17617784
[No Abstract] [Full Text] [Related]
14. [Successful combined therapy with ATG, cyclosporin and G-CSF for both liver dysfunction and bone marrow failure in hepatitis-associated aplastic anemia].
Adachi Y; Usuki K; Kazama H; Iki S; Matsuya S; Urabe A
Rinsho Ketsueki; 2001 Sep; 42(9):691-5. PubMed ID: 11680980
[TBL] [Abstract][Full Text] [Related]
15. Immunosuppression with ALG and CsA is first line treatment in children with SAA lacking an HLA identical sibling.
Békássy AN; Locasciulli A; Marsh JC; Socié G; Fuehrer M; Passweg J
Pediatr Blood Cancer; 2005 Sep; 45(3):359-60; author reply 361-2. PubMed ID: 15940724
[No Abstract] [Full Text] [Related]
16. Hepatitis-associated aplastic anaemia treated successfully with antilymphocyte globulin.
Bhattacharyya M; Oakervee H; Dalley C; Glynn M; Cavenagh J
Clin Lab Haematol; 2005 Oct; 27(5):331-3. PubMed ID: 16178916
[TBL] [Abstract][Full Text] [Related]
17. Diagnosis and treatment of acquired aplastic anemia.
Bacigalupo A; Passweg J
Hematol Oncol Clin North Am; 2009 Apr; 23(2):159-70. PubMed ID: 19327577
[TBL] [Abstract][Full Text] [Related]
18. Treatment with the chimeric anti-IL-2Ralpha basiliximab affects both the IL-2 and IL-15 signalling pathways after clinical kidney transplantation.
Boelaars-van Haperen MJ; Baan CC; van Riemsdijk IC; IJzermans JN; Weimar W
Transplant Proc; 2001; 33(1-2):1007-8. PubMed ID: 11267166
[No Abstract] [Full Text] [Related]
19. [Immunosuppressive therapy for aplastic anemia--review].
Xu CY
Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2005 Apr; 13(2):348-52. PubMed ID: 15854308
[TBL] [Abstract][Full Text] [Related]
20. Basiliximab lowers the cyclosporine therapeutic threshold in the early post-kidney transplant period.
Balbontin F; Kiberd B; Fraser A; Kiberd M; Lawen J
Clin Transplant; 2005 Apr; 19(2):225-9. PubMed ID: 15740559
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
